Abstract Search

ea0056gp95 | Diabetes Therapy | ECE2018

Randomized control study to compare security and efficacy of the new long acting analogues degludec and glargina U300 in people with type 1 Diabetes. Preliminary results of the Ineox study

Dominguez-Lopez Marta Elena , Vallejo Rosario , Morillas Virginia , Colomo Natalia , Guerrero Mercedes , Rojo Gema , de Adana Navas Marisol Ruiz

Background: There arent published randomized studies comparing the clinical impact of degludec and Glragina U300 in the treatment of type 1 diabetes patients. (T1DP)Objective: To compare efficacy and safety of the new long acting analogues Glargine U 300 and Degludec in 300 Type1 diabetes patients treated with basal/bolus treatment.(BBT)Material and methods: Randomized control study 1.1 in 300 T1DP treated with BBT with glarg...

0 shares

Endocrine Abstracts

Randomized control study to compare security and efficacy of the new long acting analogues degludec and glargina U300 in people with type 1 Diabetes. Preliminary results of the Ineox study

BiosciAbstracts